Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New macrolides]

H Portier1, M Buisson, P Chavanet

  • 1Service des maladies infectieuses et tropicales, CHU du Bocage, Dijon.

La Revue Du Praticien
|June 15, 1994
PubMed
Summary
This summary is machine-generated.

New macrolide antibiotics like azithromycin offer improved activity against Gram-negative bacteria and prolonged half-lives, potentially shortening treatment durations for infections such as pharyngitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vivo</i> efficacy of enmetazobactam combined with cefepime in a murine pneumonia model induced by OXA-48-producing <i>Klebsiella pneumoniae</i>.

Microbiology spectrum·2024
Same author

Development of a new <i>Acinetobacter baumannii</i> pneumonia rabbit model for the preclinical evaluation of future anti-infective strategies.

Microbiology spectrum·2024
Same author

Efficacy of ceftaroline and rifampin, alone or combined, in a rat model of methicillin-resistant <i>Staphylococcus epidermidis</i> osteomyelitis without implant.

Microbiology spectrum·2023
Same author

Antibiotic therapy in the emergency room: Optimal prescription is indeed the best.

Infectious diseases now·2023
Same author

Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?

Antimicrobial agents and chemotherapy·2021
Same author

Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2021
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Context:

  • Macrolides are established antibiotics in general practice.
  • Newer 14- or 15-membered ring macrolides (roxithromycin, clarithromycin, dirithromycin, azithromycin) represent potential advancements.

Purpose:

  • To review the antibacterial spectrum, pharmacokinetic properties, and clinical applications of new macrolide antibiotics.
  • To evaluate their efficacy and tolerance in various infections.

Summary:

  • New macrolides exhibit antibacterial activity similar to erythromycin, with azithromycin showing enhanced efficacy against Gram-negative strains.
  • Roxithromycin achieves high serum concentrations, while azithromycin and dirithromycin have lower concentrations but longer half-lives, enabling shorter treatment courses, especially for pharyngitis.

Related Experiment Videos

  • Macrolides are less effective for otitis and sinusitis due to weak activity against H. influenzae and S. pneumoniae.
  • Their potent activity against atypical bacteria makes them a first-line choice for atypical pneumonia in young adults and sexually transmitted diseases.
  • In AIDS patients, clarithromycin is indicated for mycobacteriosis, bacillary angiomatosis, and Rhodococcus equi pneumonia.

    • Impact:

    • These macrolides demonstrate good clinical tolerance, particularly gastrointestinal tolerance.
    • Understanding their specific applications and limitations optimizes their use in treating bacterial infections.
    • Awareness of potential drug interactions common to this antibiotic class is crucial for safe prescribing.